Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2023-09-12 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
独立董事关于第五届董事会第三十六次（临时）会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on various matters related to the company's board meeting, including nomination of board candidates, director remuneration, a 2023 restricted stock incentive plan, and the use of previously raised funds. It references compliance with laws and regulations, board procedures, and shareholder meeting submissions. The content focuses on governance and board-related decisions rather than financial results or earnings. It is not a full annual or interim report, nor an earnings release or audit report. It is not a proxy solicitation or voting results announcement. The document is a formal governance-related statement by independent directors on board and shareholder meeting matters, fitting the category of Board/Management Information (MANG). The document length is 3540 characters, which is relatively short but contains substantive governance content rather than just an announcement or certification. Therefore, the best classification is MANG with high confidence.
2023-09-12 Chinese
关于董事会换届选举的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election and nomination of the company's new board of directors, including both independent and non-independent directors. It details the nomination process, candidate qualifications, and compliance with relevant laws and regulations. There is no financial data, earnings information, or report publication mentioned. The content focuses on board/management changes and governance matters. Therefore, the document fits the category of Board/Management Information (MANG). The document length (6866 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2023-09-12 Chinese
第五届监事会第三十四次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at a supervisory board meeting (监事会会议决议公告) of 盈康生命科技股份有限公司. It includes information about the meeting's convening, attendance, and voting results on various corporate governance matters such as nomination of supervisory board candidates, remuneration plans, stock incentive plans, and reports on prior fundraising usage. The document references compliance with company law and securities regulations, and mentions that some matters require shareholder approval. It is not a full annual or interim financial report, nor an earnings release or audit report. It is not a proxy solicitation or voting results announcement. The content focuses on board/supervisory committee decisions and governance-related resolutions. Therefore, the best fitting category is Board/Management Information (MANG). The document length is under 5,000 characters, but it contains substantive meeting resolutions, not just an announcement of a report publication, so it is not RPA or RNS. Confidence is high given the clear focus on supervisory board meeting resolutions and governance matters.
2023-09-12 Chinese
关于2023年半年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "专项报告" (special report) on the storage and use of funds raised in the first half of 2023. It details the amount of funds raised, usage during the reporting period (Jan 1 to June 30, 2023), balances, management and storage of the raised funds, and compliance with regulatory requirements. The document references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange regarding the management and use of raised funds. It includes detailed financial figures related to fundraising and usage but is focused specifically on the use of raised capital rather than a full financial report or earnings release. The document length is 3966 characters, which is relatively short and focused on a specific topic. This matches the characteristics of a Capital/Financing Update (CAP) filing, which covers updates on fundraising and capital usage. It is not an Annual Report, Interim Report, or Earnings Release, nor is it a general regulatory filing or announcement of a report. Therefore, the best classification is CAP with high confidence.
2023-08-29 Chinese
2023年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "盈康生命科技股份有限公司2023 年半年度报告全文" which translates to "Inkon Life Technology Co., Ltd. 2023 Semi-Annual Report Full Text." It contains detailed financial data, management discussion and analysis, company overview, accounting policy changes, and operational details for the period January 1, 2023 to June 30, 2023. The document includes comprehensive financial statements and analysis, which are characteristic of an Interim / Quarterly Report. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is the report itself, not an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2023
2023-08-29 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of 盈康生命科技股份有限公司 regarding the third thirty-third meeting of the fifth Supervisory Board. It includes approvals of the 2023 semi-annual report, a special report on the use of raised funds, and a related party transaction. The document references the 2023 semi-annual report and other detailed reports published elsewhere but does not contain the actual financial statements or detailed financial data itself. The document is relatively short (1655 characters) and serves as an official meeting resolution announcement rather than the full interim report. Therefore, it is best classified as a Regulatory Filing (RNS) because it is an official announcement of meeting resolutions and approvals, not the full interim report or financial statements.
2023-08-29 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.